Brief introduction of Shanxi federal pharmaceutical co., ltd.

The legal representatives are Hou Xiaobin and Li Yun (husband and wife). Business scope: production and sales: tablets (including cephalosporins), hard capsules, granules, suppositories, psychotropic drugs, etc. The enterprise has passed the pharmaceutical production license and the provincial GMP certification, with the certificate numbers of Jin F0023 and Jin H00 17. The enterprise has 200 employees, including 20 managers; 8. Scientific and technical personnel; 3 marketers and 3 senior titles; Intermediate title 10 person. Managers and employees are professionals who have been recruited through formal channels, engaged in management work in large state-owned enterprises and graduated from formal institutions. Familiar with the pharmaceutical industry, strict management system, employees optimistic about the development prospects of enterprises, harmonious labor relations. Total assets are 43.52 million yuan, including current assets11439,500 yuan and fixed assets (main equipment) of 26.877 million yuan; Total liabilities are18.702 million yuan. Among them, current liabilities (short-term liabilities) are 4 million yuan, and owners' equity is 25,538,400 yuan.

Jiangxi Xier Kangtai Pharmaceutical Co., Ltd. is a pharmaceutical enterprise jointly invested by Hou Xiaobin and Li Yun. The company is located in Pingxiang Economic Development Zone, Jiangxi Province. The total assets of the company are more than 73 million yuan, covering an area of 654.38+10,000 square meters, with a building area of 1.8 million square meters. At present, there are more than 400 employees, among whom pharmacy and related professional and technical personnel account for more than 30%.

The company has eight modern preparation workshops, which can produce tablets (containing hormones), capsules, eye drops, eye ointments (containing hormones), ointments, creams (containing hormones), ointments, solutions (containing hormones), liniments, western medicine raw materials, Chinese medicine raw materials and so on 10 dosage forms.

All dosage forms and workshops of the two pharmaceutical companies have passed the GMP certification of the national or provincial food and drug administration.

Jiangxi Xier Kangtai Pharmaceutical Co., Ltd. has 67 drug production approval numbers approved by the US Food and Drug Administration in China, and Shaanxi Federal Pharmaceutical Co., Ltd. has 32 drug production approval numbers. At the same time, the two companies registered more than 1000 drug varieties in more than 20 countries, including Pakistan, Nigeria, Congo, Philippines and Zimbabwe, and produced more than 500 kinds of pharmaceutical preparations in nearly 20 dosage forms.